Clinical retrospective analysis of 218 cases of infectious endophthalmitis

对218例感染性眼内炎病例进行临床回顾性分析

阅读:1

Abstract

PURPOSE: Endophthalmitis is a serious medical condition that needs immediate antibiotic therapy. There are few studies analyzing the pathogenic bacteria of endophthalmitis in China recently. This study was conducted to analyze the pathogenic factors, pathogenic bacteria and prognosis of infectious endophthalmitis. METHODS: A cross-sectional study was conducted from January 2016 to December 2020 in Shanxi Eye Hospital. Statistical analysis by using Logistic regression analysis were performed to evaluate of independent risk factor for prognostic factors for poor visual acuity. RESULTS: Positive case of specimen culture was detected in 96 cases, accounting for 44.04%. Staphylococcus epidermidis, the most common bacteria, accounted for 32.98% (31/94), mainly in traumatic endophthalmitis and postoperative endophthalmitis, and was extremely sensitive to vancomycin (96.77%). The Gram-positive bacteria were highly sensitive to vancomycin (87.01%) and relatively sensitive to levofloxacin (68.83%). Gram-negative bacteria were highly sensitive to levofloxacin (88.24%). 12.39% of patients with visual acuity > 0.02 at admission and 27.98% at discharge, the difference was statistically significant (χ(2) = 17.449, P < 0.001). Logistic regression analysis of traumatic endophthalmitis group showed that intraocular foreign body was an independent risk factor for poor visual acuity after post-operation (OR = 2.215. P = 0.016). CONCLUSIONS: As society progresses and hygiene concepts increase in China, the bacteria that cause infection are changing, and factors that influence prognosis may also be changing. Clarifying the different causative factors and etiological characteristics of infectious endophthalmitis are important to provide appropriate clinical treatment.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。